Follow the people · Insider
Joanne Wendy Kim
Joanne Wendy Kim files insider transactions with the SEC as a chief financial officer of Biovie (BIVI). We hold 1 disclosed purchase or sale filed since 21 October 2020, 1 of them in the last 90 days.
- Files forBIVI
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure28 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 20 August 2021 — 28 August 2026Chief Financial Officer · Biovie (BIVI)15 Form 4 lines · source: SEC Form 4
- Filed 1 October 2019 — 1 October 2020Chief Financial Officer · Biovie (bivi)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
17 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 2,500 shares of BiovieSEC Form 428 August 2026Common Stock · traded 28 August 2026 · filed 28 August 2026
- was granted 110,100 shares of Biovie (a derivative holding)SEC Form 49 January 2026Stock Option (right to buy) · traded 5 January 2026 · filed 9 January 2026
- was granted 110,100 shares of Biovie (a derivative holding)SEC Form 49 January 2026Stock Option (right to buy) · traded 5 January 2026 · filed 9 January 2026
- was granted 14,417 shares of Biovie (a derivative holding)SEC Form 47 January 2025Stock Option (right to buy) · traded 20 December 2024 · filed 7 January 2025
- was granted 99,000 shares of Biovie (a derivative holding)SEC Form 412 July 2024Stock Option (right to buy) · traded 24 June 2024 · filed 12 July 2024
- had shares withheld for tax on 2,476 shares of BiovieSEC Form 412 July 2024Common Stock · traded 16 February 2023 · filed 12 July 2024
- had shares withheld for tax on 2,476 shares of BiovieSEC Form 412 July 2024Common Stock · traded 15 February 2024 · filed 12 July 2024
- was granted 73,000 shares of BiovieSEC Form 412 July 2024Common Stock · traded 24 June 2024 · filed 12 July 2024
- had shares withheld for tax on 18,250 shares of BiovieSEC Form 412 July 2024Common Stock · traded 24 June 2024 · filed 12 July 2024
- was granted 5,000 shares of BiovieSEC Form 413 December 2023Common Stock · traded 11 December 2023 · filed 13 December 2023
- was granted 20,000 shares of Biovie (a derivative holding)SEC Form 43 July 2023Stock Option (right to buy) · traded 7 June 2023 · filed 3 July 2023
- had shares withheld for tax on 2,476 shares of BiovieSEC Form 422 February 2023COMMON STOCK · traded 16 February 2023 · filed 22 February 2023
- was granted 39,624 shares of BiovieSEC Form 418 January 2023COMMON STOCK · traded 23 November 2022 · filed 18 January 2023
- ▲ bought on the open market 2,000 shares of BiovieSEC Form 49 December 2021Class A common stock, par value $0.0001 · traded 7 December 2021 · filed 9 December 2021
- was granted 124,167 shares of Biovie (a derivative holding)SEC Form 416 September 2021Stock Option (right to buy) · traded 20 August 2021 · filed 16 September 2021
- was granted 800 shares of Biovie (a derivative holding)SEC Form 421 October 2020options · traded 1 October 2019 · filed 21 October 2020
- was granted 800 shares of Biovie (a derivative holding)SEC Form 421 October 2020options · traded 1 October 2020 · filed 21 October 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.